Company type | Public |
---|---|
NSE: METROPOLIS BSE: 542650 | |
ISIN | INE112L01020 |
Industry | Health and Medical Services |
Founded | 1980 |
Founder | Dr. Sushil Kanubhai Shah |
Headquarters | , India |
Number of locations | 124 clinical laboratories across 7 countries |
Area served | |
Key people |
|
Services | Health care management |
Revenue | ₹1,228 crore (US$150 million) (FY22) [2] |
₹214 crore (US$26 million) (FY22) [2] | |
Number of employees | 4600+ (2021) [3] |
Website | www |
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories [4] and 2400 collection centers across 7 countries including India. [5] The healthcare company was founded in 1980. The company went public in April 2019. [6]
Metropolis was founded by Dr. Sushil Kanubhai Shah in 1980. [7] The healthcare company was started as a single diagnostic laboratory in Mumbai. Shah's daughter, Ameera Shah, took over the pathology business in 2001. The company started out by partnering with local and regional diagnostic chains, thereby spreading its reach across the country. Metropolis Healthcare has expanded into new service areas, like Clinical Research, Hospital Lab Management and Wellness Solutions, in the past decade. [8] Metropolis Healthcare began its international expansion in 2005 with Sri Lanka being the first market. It further expanded to UAE in 2006, followed by Kenya in 2013 [9] and Mauritius [10] [11] and Ghana [12] in 2014.
In February 2018, Metropolis partnered with National Aids Control Organisation (NACO) for a three-year project for diagnosis of HIV at 560 locations in India. [13] [14] As of 2018, the diagnostic chain consists of 124 clinical laboratories and 2400 blood collection centers [5] [7] across India, Ghana, Kenya, Zambia, Uganda, Mauritius and Sri Lanka.[ citation needed ]
In October 2019, Metropolis Healthcare acquired four individual laboratories, Doctor's Clinical Laboratory, Iyer Pathology Laboratory, Nagar Pathology Laboratory and Yash Clinical Laboratory, a subsidiary of Dr Lal PathLabs in Surat, Gujarat, for INR 18 crore. The acquisition was done in order to expand the penetration of Metropolis's wholly owned subsidiary Desai Laboratories. [15] [16]
In October 2021, Metropolis completed the acquisition of South Indian diagnostic chain Hitech Diagnostic Centre and its subsidiary Centralab Healthcare Services for ₹636 crore. [17] [18]
ICICI Venture invested 35 crore in Metropolis in the year 2006 through its India Advantage Fund. In 2010, Warburg Pincus invested about $85 Million in Metropolis, paving a way for ICICI to exit. [19] The Shah family purchased the exiting stake from Warburg Pincus for a healthy return on investment. [20] The company is backed by several investors including Carlyle Group, CA Lotus Investments [21] and Kohlberg Kravis Roberts (KKR). In 2015, KKR backed Ameera Shah through ₹5.6 billion (equivalent to ₹8.5 billionorUS$100 million in 2023) promoter debt funding. [22]
In April 2019, the company raised Rs 530 crore from 26 anchor investors, including Small Cap World Fund, Neuberger Berman Emerging Market Equity Fund, Fundsmith Emerging Equities Trust PLC and First State Indian Sub Continent Fund, among others. [23]
Metropolis was awarded the Diagnostic Services Company of the Year by Frost & Sullivan in 2010. [24] In 2014, it was awarded India's Most Promising Brand by the World Consulting and Research Corporation, which was evaluated by Ernst & Young. [25] [26] In 2018 and 2017, MD of Metropolis, Ameera Shah was ranked 36th and 46th respectively, in "India's Most Powerful Women in Business" by Fortune India Magazine. [27] [28] in 2015, Shah was awarded as one of the Asia's Power Business Women by Forbes. [29]
In April 2017, Metropolis launched a scholarship and mentorship program, called "Medengage", for undergraduate and postgraduate medical students across India. [30] In July 2017, Metropolis and the PCOS Society of India launched a Polycystic Ovarian Syndrome (PCOS) awareness campaign called "Conquer PCOS". [31] In August 2018, Metropolis initiated an "Umbrella Handshake" campaign to create awareness about health. The company donated ₹2 million (equivalent to ₹2.7 millionorUS$32,000 in 2023) towards this and other social welfare initiatives. Metropolis partnered with We Foundation and Red FM, to help in public outreach and campaign awareness. [32]
Warburg Pincus LLC is a global private equity firm, headquartered in New York City, with offices in the United States, Europe, Brazil, China, Southeast Asia and India. Warburg has been a private equity investor since 1966. As of April 2024 the firm had over $90 billion in assets under management and invests in a range of sectors including retail, industrial manufacturing, energy, financial services, health care, technology, media, and real estate. Warburg Pincus is a growth investor. Warburg Pincus has raised 21 private equity funds which have invested over $100 billion in over 1,000 companies in 40 countries.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Apollo Hospitals Enterprise Limited is an Indian multinational healthcare group headquartered in Chennai. It is the largest for-profit private hospital network in India, with a network of 71 owned and managed hospitals. Along with the eponymous hospital chain, the company also operates pharmacies, primary care and diagnostic centres, telehealth clinics, and digital healthcare services among others through its subsidiaries.
Tata Technologies Limited is an Indian multinational technology company engaged in product engineering, that provides services to automotive and aerospace original equipment manufacturers as well as industrial machinery companies. It is a subsidiary of Tata Motors.
Sonic Healthcare Limited is a Sydney-based, Australian company that provides laboratory services, pathology, radiology services and Primary care medical services.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Max Healthcare Institute Limited is an Indian for-profit private hospital chain headquartered in Delhi. Max Healthcare operates 19 hospitals with more than 4,000 beds, primarily in North India.
Kalyan Jewellers is an Indian jewellery chain founded by T. S. Kalyanaraman in 1993.
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
Aster DM Healthcare Limited is a multinational for-profit private hospital network founded by Dr. Azad Moopen in 1987. The company has its corporate headquarters in Dubai, UAE, and is registered in Bengaluru, India. Aster DM Healthcare currently operates hospitals, medical centres, diagnostic centres, laboratories and pharmacies in six GCC countries and India. The corporation works in a variety of economic sectors through its brands Aster, Medcare, and Access.
Ameera Shah (born 24 September 1979) is an Indian entrepreneur. She is Executive Chairperson and Whole-time Director of Metropolis Healthcare, a leading diagnostic chain with presence in India and Africa. She is the daughter of Dr Sushil Shah, the founder of Metropolis Healthcare.
Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera.
Arvind Lal is an Indian billionaire, pathologist, medical administrator and the chairman and managing director of Dr Lal PathLabs, a medical diagnostic centre in Delhi. A medical graduate and a medical academic, he is reported to have modernized Indian medical diagnostics and initiated the first Public Private Partnership (PPP) in the field of laboratory testing in India. He holds the rank of a Brigadier in the Indian Armed Forces, an honorary rank conferred by the Army. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2009, for his contributions to Medicine.
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
Agilus Diagnostics Limited is an Indian multinational diagnostics company providing diagnostic services in pathology and radiology. Agilus Diagnostics has its headquarters and corporate office in Gurgaon.
Lenskart is an Indian multinational optical prescription eyewear retail chain, based in Gurugram. As of March 2023, Its manufacturing facility in New Delhi manufactures 3 lakh glasses a month. Lenskart is building an automated factory in Bhiwadi, Rajasthan, with an annual production capacity of 5 crore glasses.
Max Group is an Indian conglomerate headquartered in New Delhi, operating in the fields of life insurance, healthcare, hospitality, real estate and independent senior living. It was founded in 1985 by Analjit Singh.
Duru Shah is a Mumbai-based gynaecologist academic and women activist. She is the Founder President of the PCOS Society, India and a promoter of adolescent girls and women's health and infertility in India. Shah is also the promoter of Metropolis Healthcare Ltd. She is also a Consultant ObGyn.: Breach Candy Hospital, Jaslok Hospital, Mumbai.
Home First Finance Company India Limited is an Indian housing finance company in the affordable housing segment based in Mumbai and founded in 2010. It provides home loans, mortgage loans and home construction loans. Its equity shares are listed on Bombay Stock Exchange and National Stock Exchange.
Meril Life Sciences is an Indian multinational medical device company, with headquarters in Vapi, Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group. The company is engaged in the manufacturing of vascular intervention devices, orthopedic implants, endosurgery, ENT products and in-vitro diagnostics. Meril Life Sciences operates in over 100 countries and has employed 4000 people, as of 2022.
{{cite news}}
: |first=
has generic name (help)